Fludarabine,Bendamustine
Bayer,teva,Tessa Therapeutics
['tessa']
new data from #chariot study of autologous #cartcell therapy #tt11 demonstrated a 73.3% overall response rate and 60% complete response rate; ctdna identified as a potential efficacy biomarker: #ash22 #tessaash22 #cancer
Tessa Therapeutics is a clinical-stage biotech company focused on cancer treatment through the development of autologous and allogeneic cell therapies.